13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 30 holding rows worth $621,886,000.
- Accession
- 0001831942-22-000007
- Filer
- CIK 1831942
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 30 entries on the cover page, a total value of $621,886,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $621,886,000 with VALUE read as thousands by filing date, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,319,940 | $64,454,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,594,932 | $57,577,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,696,340 | $55,302,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 5,128,557 | $54,158,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 2,615,762 | $52,394,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 893,646 | $43,297,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,410,622 | $37,943,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 743,472 | $25,315,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 3,711,286 | $22,268,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,975,403 | $20,702,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 5,738,500 | $20,085,000 | thousands by filing date | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,018,569 | $19,322,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 738,110 | $17,737,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 538,812 | $15,146,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 739,661 | $14,815,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 404,078 | $13,355,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 899,407 | $12,286,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,100,000 | $11,033,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 1,935,609 | $10,568,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 1,643,500 | $10,058,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,325,000 | $9,540,000 | thousands by filing date | |
| CELCUITY INC | 15102K100 | COM | 920,464 | $9,241,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 103,494 | $5,368,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 312,553 | $4,535,000 | thousands by filing date | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,210,000 | $3,315,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 467,468 | $3,132,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 893,013 | $2,822,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 250,000 | $2,505,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 750,000 | $2,400,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 205,870 | $1,213,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-22-000007 | this filing | 2022-11-14 | acceptance time not in the bulk data set |